# Grifols Therapeutics LLC, Clayton, NC – FDA Inspections

Source: https://www.keypedia.com/companies/grifols-therapeutics-llc/2e4dd489-4e70-4ef7-a1f8-f0267f91fab5

> Inspection records and compliance data for Grifols Therapeutics LLC in Clayton, North Carolina. 9 FDA inspections on record, 5 Form 483s, last inspected February 05, 2026.

---

## Details

- Name: Grifols Therapeutics LLC
- FEI Number: 1050373
- Address Line 1: 8368 Us 70 Bus Hwy W
- City: Clayton
- State: North Carolina
- Zip Code: 27520
- Country Name: United States
- Address: 8368 Us 70 Bus Hwy W, Clayton, North Carolina 27520, United States
- Country: United States

## Related Documents

- [483 - Grifols Therapeutics LLC - Unknown Date](https://www.keypedia.com/records/483/grifols-therapeutics-llc/179dc664-3ece-4464-a4cb-445c085a3e16) — source: FDA, date: Invalid Date
- [483 - Grifols Therapeutics LLC - Unknown Date](https://www.keypedia.com/records/483/grifols-therapeutics-llc/9b3fca0f-5880-4793-ac91-143400fc36bf) — source: FDA, date: Invalid Date
- [483 - Grifols Therapeutics LLC - Unknown Date](https://www.keypedia.com/records/483/grifols-therapeutics-llc/7dbd0e3f-4f85-4319-b54c-fcbb5a82d5d4) — source: FDA, date: Invalid Date
- [483 - Grifols Therapeutics LLC - 2026-02-05](https://www.keypedia.com/records/483/grifols-therapeutics-llc/f00000c6-d7fa-4773-9efc-0d7051024010) — source: FDA, date: February 5, 2026
- [FDA Inspection 1302186 - Grifols Therapeutics LLC - 2026-02-05](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/34708a56-41e8-4e87-bab0-c702d71a2713) — source: FDA, date: February 5, 2026
- [483 - Grifols Therapeutics LLC - 2023-09-01](https://www.keypedia.com/records/483/grifols-therapeutics-llc/a0027827-e11c-4401-8d9e-736ea37fded6) — source: FDA, date: September 1, 2023
- [FDA Inspection 1221101 - Grifols Therapeutics LLC - 2023-09-01](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/8955f0eb-74f7-40f8-be3a-2ebaa64a50c8) — source: FDA, date: September 1, 2023
- [483 - Grifols Therapeutics LLC - 2022-05-06](https://www.keypedia.com/records/483/grifols-therapeutics-llc/d4734f09-a3e5-4c43-91a5-d5af64a9f8d4) — source: FDA, date: May 6, 2022
- [EIR - Grifols Therapeutics LLC - 2022-05-06](https://www.keypedia.com/records/eir/grifols-therapeutics-llc/669ab472-596a-4a2d-9260-1418fe0eb8cd) — source: FDA, date: May 6, 2022
- FDA Inspection 1176467 - Grifols Therapeutics LLC - 2022-05-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 6, 2022
- [FDA Inspection 1176467 - Grifols Therapeutics LLC - 2022-05-06](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9cf52920-d34b-4f87-840d-e52213631e5a) — classification: No Action Indicated (NAI), source: FDA, date: May 6, 2022
- [483 - Grifols Therapeutics LLC - 2018-12-13](https://www.keypedia.com/records/483/grifols-therapeutics-llc/f336deae-08c7-4cf7-9256-f71f7bf699a9) — source: FDA, date: December 13, 2018
- [EIR - Grifols Therapeutics LLC - 2018-12-13](https://www.keypedia.com/records/eir/grifols-therapeutics-llc/32fb0695-4a70-4b07-8eb5-312e0f5fbac0) — source: FDA, date: December 13, 2018
- [FDA Inspection 1079999 - Grifols Therapeutics LLC - 2018-12-13](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/a8c4df93-a1d3-415f-a6ee-5067a6f6675c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2018
- [FDA Inspection 1003199 - Grifols Therapeutics LLC - 2017-02-10](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/cd7b9835-ca8b-4844-95da-18ed498be896) — source: FDA, date: February 10, 2017
- [483 - Grifols Therapeutics LLC - 2016-10-21](https://www.keypedia.com/records/483/grifols-therapeutics-llc/e52d20cd-cb5a-4136-b15c-0bb2a128c9ec) — source: FDA, date: October 21, 2016
- [FDA Inspection 994781 - Grifols Therapeutics LLC - 2016-10-21](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9a41f385-bd40-454e-bfcf-1cf95a896584) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 21, 2016
- FDA Inspection 879629 - Grifols Therapeutics LLC - 2014-04-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 1, 2014
- FDA Inspection 710839 - Grifols Therapeutics LLC - 2011-01-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2011
- FDA Inspection 599585 - Grifols Therapeutics LLC - 2009-04-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 24, 2009

## Related Companies

- [Octapharma Produktionsgesellschaft Deutschland mbH](https://www.keypedia.com/companies/octapharma-produktionsgesellschaft-deutschland-mbh/6a1a14b1-f958-4ba6-b283-5c92ef67a783)
- [Adimmune Corporation](https://www.keypedia.com/companies/adimmune-corporation/ef2a0feb-a3b7-45e4-91a6-15d344543027)
- [CSL Behring GmbH](https://www.keypedia.com/companies/csl-behring-gmbh/21a38e53-2e5d-4c9e-a287-79597f091cc6)
- [CSL Behring (Australia) Pty Ltd](https://www.keypedia.com/companies/csl-behring-australia-pty-ltd/85c32ac7-6cc3-45f8-a596-8d36e2671f59)
- [Krystal Biotech, Inc.](https://www.keypedia.com/companies/krystal-biotech-inc/a9722688-fbec-493a-b344-89b3fb41b9ab)
- [Neurotech Pharmaceuticals, Inc.](https://www.keypedia.com/companies/neurotech-pharmaceuticals-inc/54a73df4-05e1-44cd-970b-9655a03d1d53)
- [ADMA Biologics, Inc](https://www.keypedia.com/companies/adma-biologics-inc/dcb996fb-4a71-44fe-87f1-cfe3979d4182)
- [GenIbet Biopharmaceuticals, S.A.](https://www.keypedia.com/companies/genibet-biopharmaceuticals-sa/0caa1843-f97a-4138-b02a-16af961df290)
- [CSL Behring L.L.C.](https://www.keypedia.com/companies/csl-behring-llc/bb057a50-8ebe-4207-b535-b5ecc4b342d9)
- [Kedrion Biopharma Inc.](https://www.keypedia.com/companies/kedrion-biopharma-inc/e6cf606f-c996-4278-ad90-ec69fbd2a7f7)

## Related Officers

- [Laurel A. Beer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)
- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [company_representative](https://www.keypedia.com/people/sergi-roura/2757463d-6b0b-4d9b-bffd-e39700889ae6)
- [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)
- [investigator](https://www.keypedia.com/people/yonggang-wang/5c7dd00f-f810-4f86-9c78-51ae7f4b8acd)
- [Kula Jha, Ph.D.](https://www.keypedia.com/people/kula-jha-phd/9f0eddc7-93bc-40c1-a0f0-863a82f5ff03)
